Literature DB >> 16235272

Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults.

M J Parker1, H H G Handoll.   

Abstract

BACKGROUND: Two types of implants used for the surgical fixation of extracapsular hip fractures are cephalocondylic intramedullary nails, which are inserted into the femoral canal proximally to distally across the fracture, and extramedullary implants.
OBJECTIVES: To compare cephalocondylic intramedullary nails with extramedullary implants (e.g. the sliding hip screw) for extracapsular hip fractures in adults. SEARCH STRATEGY: We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (June 2005), the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, the UK National Research Register, orthopaedic journals, conference proceedings and reference lists of articles. SELECTION CRITERIA: All randomised and quasi-randomised controlled trials comparing cephalocondylic nails with extramedullary implants for extracapsular hip fractures. DATA COLLECTION AND ANALYSIS: Both authors independently assessed trial quality and extracted data. Wherever appropriate, results were pooled. MAIN
RESULTS: Predominantly older people with mainly trochanteric fractures were treated in the 32 included trials. Twenty trials, involving 3646 people, compared the Gamma nail with the sliding hip screw (SHS). The Gamma nail was associated with an increased risk of operative and later fracture of the femur and an increased reoperation rate. There were no major differences between implants in the wound infection, mortality or medical complications. Data were inadequate for other outcomes. Five trials, involving 623 people, compared the intramedullary hip screw (IMHS) with the SHS. Fracture fixation complications were more common in the IMHS group: all cases of operative and later fracture of the femur occurred in this group. Results for post-operative complications, mortality and functional outcomes were similar in the two groups. Two trials involving 314 people showed no difference in fracture fixation complications, reoperation, wound infection and length of hospital stay for proximal femoral nail (PFN) compared with the SHS. Single trial comparisons (experimental mini-invasive static intramedullary nail compared with the SHS: 60 participants; Kuntscher-Y nail with the SHS: 230 participants; Gamma nail and the Medoff sliding plate: 217 participants) failed to provide sufficient evidence to establish differences between implants in outcome. Two trials, involving 65 people with reverse and transverse fractures at the level of the lesser trochanter, found intramedullary nails (Gamma nail or PFN) were associated with better intra-operative results and fewer fracture fixation complications than extramedullary implants (a 90-degree blade plate or dynamic condylar plate) for these fractures. AUTHORS'
CONCLUSIONS: Given the lower complication rate of the SHS in comparison with intramedullary nails, SHS appears superior for trochanteric fractures. Further studies are required to determine if different types of intramedullary nail produce similar results, or if intramedullary nails have advantages for selected fracture types (for example, subtrochanteric fractures).

Entities:  

Mesh:

Year:  2005        PMID: 16235272     DOI: 10.1002/14651858.CD000093.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  18 in total

1.  Comparison of functional recovery in the very early period after surgery between plate and nail fixation for correction of stable femoral intertrochanteric fractures: a controlled clinical trial of 18 patients.

Authors:  Koun Yamauchi; Kazunari Fushimi; Goshi Shirai; Masashi Fukuta
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-06

Review 2.  [Trochanteric femoral fractures: anatomy, biomechanics and choice of implants].

Authors:  F Bonnaire; T Lein; P Bula
Journal:  Unfallchirurg       Date:  2011-06       Impact factor: 1.000

3.  Surgical approach to bone healing in osteoporosis.

Authors:  Vito Pesce; Domenico Speciale; Giulio Sammarco; Silvio Patella; Antonio Spinarelli; Vittorio Patella
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

4.  Does PFNA II avoid lateral cortex impingement for unstable peritrochanteric fractures?

Authors:  George A Macheras; Stefanos D Koutsostathis; Spyridon Galanakos; Konstantinos Kateros; Stamatios A Papadakis
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

5.  Preoperative classification assessment reliability and influence on the length of intertrochanteric fracture operations.

Authors:  Jing Shen; FangKe Hu; LiHai Zhang; PeiFu Tang; ZhengGang Bi
Journal:  Int Orthop       Date:  2012-12-21       Impact factor: 3.075

6.  Comparing two intramedullary devices for treating trochanteric fractures: a prospective study.

Authors:  Konstantinos G Makridis; Vasileios Georgaklis; Miltiadis Georgoussis; Vasileios Mandalos; Vasileios Kontogeorgakos; Leonidas Badras
Journal:  J Orthop Surg Res       Date:  2010-02-18       Impact factor: 2.359

Review 7.  Influence of osteoporosis on fracture fixation--a systematic literature review.

Authors:  J Goldhahn; N Suhm; S Goldhahn; M Blauth; B Hanson
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

8.  Intertrochanteric fractures: comparison between two different locking nails.

Authors:  Carmelo D'Arrigo; Alessandro Carcangiu; Dario Perugia; Simone Scapellato; Raffaella Alonzo; Silvia Frontini; Andrea Ferretti
Journal:  Int Orthop       Date:  2012-10-28       Impact factor: 3.075

9.  Is a sliding hip screw or im nail the preferred implant for intertrochanteric fracture fixation?

Authors:  Brian Aros; Anna N A Tosteson; Daniel J Gottlieb; Kenneth J Koval
Journal:  Clin Orthop Relat Res       Date:  2008-05-09       Impact factor: 4.176

10.  [Trochanteric and subtrochanteric fractures].

Authors:  C Bahrs; A Schreiner; U Stöckle; T Klopfer; P Hemmann
Journal:  Chirurg       Date:  2018-10       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.